Wright Medical Group, Inc. (NASDAQ:WMGI) shares have a current ABR (average broker recommendation) of N/A. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.
Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Wright Medical Group, Inc. (NASDAQ:WMGI). The highest current target is $N/A. The lowest price target out of the polled analysts is presently $N/A. The consensus target price is currently noted at $N/A. Analysts may employ various techniques to help predict future stock price levels.
On the earnings front, Wright Medical Group, Inc. (NASDAQ:WMGI) is expected to post quarterly earnings per share of $N/A. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around N/A. Wright Medical Group, Inc. (NASDAQ:WMGI) most recently reported quarterly EPS of $N/A for the quarter ending N/A. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of N/A%.
For the current quarter, analysts are expecting Oracle Corporation (NYSE:ORCL) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Oracle Corporation (NYSE:ORCL) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of N/A%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Oracle Corporation (NYSE:ORCL) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Oracle Corporation (NYSE:ORCL) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.